Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Nephrology
View By:YearCompanyConditionsTherapeutic AreasDrug Names
Cipro (ciprofloxacin HCl)
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Approval Status: Approved April 1996
Treatment Area: cystitis
Cipro has been approved as treatment for acute, uncomplicated
cystitis, caused by E.coli or Staphylococcus saprophyticus.
Cystitis is one of the most common urinary tract infections (UTI)
Cipro will be available in a blister pack that contains a full
course of therapy, offering tablets to be taken twice a day for
three days with or without food.
Cipro should not be administered concurrently with
The most common side effects reported in the 100 mg CIPRO
tablets clinical trials were headache, vaginal yeast infections,
nausea, abdominal pain, dizziness, vaginitis and diarrhea. Rarely,
however, were these side effects serious enough to cause women to
Annually, more than one million women suffer from cystitis, a
bacterial infection of the urinary bladder, which causes a strong
urge to urinate, frequency or difficulty in urinating, and
abdominal/pelvic pain. Approximately one in five women will develop
a UTI during her lifetime.
Cipro tablets have been marketed by Bayer in the United States
since 1987 for the treatment of a wide variety of infectious
diseases in adults such as urinary tract, lower respiratory tract,
bone and joint, and skin structure infections.